血清乳酸脱氢酶高水平结直肠癌患者临床及预后特点

Clinicopathological features and prognosis of colorectal cancer with high LDH level

  • 摘要: 目的 回顾分析血清乳酸脱氢酶(lactate dehydrogenase,LDH)高水平患者的临床及预后特点。 方法 收集2007年1月-2012年7月在本院就诊的112例结直肠癌患者临床病理和预后资料。根据血清LDH水平分为两组,血清LDH在正常水平或正常水平以下的为LDH低水平组,高于血清LDH正常范围为LDH高水平组。分析两组间的临床病理特点及预后的差异。 结果 两组在T分期(χ2=8.210,P=0.016)、血清癌胚抗原(carcinoembryonic antigen,CEA)(χ2=6.946,P=0.008)差异有统计学意义,单因素分析LDH水平(χ2=10.312,P=0.001)、T分期(χ2=17.141,P< 0.01)、M分期(χ2=11.982,P=0.001)和血清CEA(χ2=5.823,P=0.016)与结直肠癌预后相关。LDH高水平组的1、3、5年生存率为81.5%、49.4%、42.1%;LDH低水平组为92.7%、79.4%、66.2%。多因素分析显示,LDH水平(HR=2.236,P=0.016)、T分期(HR=2.299,P=0.012)是结直肠癌预后的独立影响因素。 结论 结直肠癌患者血清LDH高水平者预后较差。

     

    Abstract: Objective To analyze the clinicopathological features and prognosis of colorectal cancer with high lactate dehydrogenase (LDH) level retrospectively. Methods Clinical pathological and prognosis data about 112 cases patients with colorectal cancer in our hospital from January 2007 to July 2012 were collected. According to the LDH level, patients were divided into high LDH and low LDH groups. The differences of clinicopathological features and prognosis between the two groups were analyzed. Results There were significant differences in T stage (χ2=8.210, P=0.016) and CEA level (χ2=6.946, P=0.008) between two groups. Univariate analysis showed that LDH level (χ2=10.312, P=0.001), T stage (χ2=17.141, P< 0.01), M stage (χ2=11.830, P< 0.01) and CEA level (χ2=6.381, P=0.012) were positively correlated with survival. The 1, 3, 5-year survival rate of high LDH group and low LDH group were 81.5%, 49.4%, 42.1% and 92.7%, 79.4%, 66.2%, respectively. The multivariate analysis showed that LDH level (HR=2.236, P=0.016) and T stage (HR=2.299, P=0.012) were independent prognostic factors for survival. Conclusion Colorectal cancer patients with high serum LDH level have poor prognosis.

     

/

返回文章
返回